These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24509755)

  • 1. A divided INN crowd.
    Schellekens H
    Nat Biotechnol; 2014 Feb; 32(2):132. PubMed ID: 24509755
    [No Abstract]   [Full Text] [Related]  

  • 2. A divided INN crowd.
    Chin WW
    Nat Biotechnol; 2014 Feb; 32(2):130. PubMed ID: 24509752
    [No Abstract]   [Full Text] [Related]  

  • 3. A divided INN crowd.
    Greenwood J
    Nat Biotechnol; 2014 Feb; 32(2):131-2. PubMed ID: 24509753
    [No Abstract]   [Full Text] [Related]  

  • 4. A divided INN crowd.
    Eich G
    Nat Biotechnol; 2014 Feb; 32(2):131. PubMed ID: 24509754
    [No Abstract]   [Full Text] [Related]  

  • 5. The INN crowd.
    Nat Biotechnol; 2013 Dec; 31(12):1055. PubMed ID: 24316620
    [No Abstract]   [Full Text] [Related]  

  • 6. Nature Biotechnology responds.
    Nat Biotechnol; 2014 Feb; 32(2):132. PubMed ID: 24509756
    [No Abstract]   [Full Text] [Related]  

  • 7. What's in a drug name?
    Wick JY
    J Am Pharm Assoc (2003); 2004; 44(1):12-4. PubMed ID: 14965147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Generic prescription should be evaluated as new way of prescription in Denmark].
    Hellebek A; Søndergaaard J; Thirstrup S; Sales Y
    Ugeskr Laeger; 2012 Aug; 174(35):1974. PubMed ID: 22929572
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosimilars and safety issues.
    Dammacco F; Abbracchio MP; Gesualdo L; Goffredo F; Ronco C; Zanella A
    Leuk Lymphoma; 2009 Apr; 50(4):656-8. PubMed ID: 19373667
    [No Abstract]   [Full Text] [Related]  

  • 10. Biosimilars: considerations for an abbreviated pathway.
    Kozlowski S; Behrman R
    Leuk Lymphoma; 2009 Apr; 50(4):527-8. PubMed ID: 19373649
    [No Abstract]   [Full Text] [Related]  

  • 11. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 12. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use caution when donating drugs, guidelines suggest.
    Riggs B
    CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855
    [No Abstract]   [Full Text] [Related]  

  • 15. Product information for generic drugs: old, unloved and sometimes unsafe.
    Doogue MP; Thynne TR
    Intern Med J; 2013 Dec; 43(12):1346-8. PubMed ID: 24330367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brand versus generic drugs.
    Feldmann EG
    J Am Pharm Assoc; 1969 Jan; 9(1):8-12. PubMed ID: 5762218
    [No Abstract]   [Full Text] [Related]  

  • 17. Dora Akunyili: battling against counterfeit drugs. Interview by Marilynn Larkin.
    Akunyili D
    Lancet Infect Dis; 2006 Sep; 6(9):554-5. PubMed ID: 16931405
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug counterfeiting burden remains a guess, experts say.
    Traynor K
    Am J Health Syst Pharm; 2009 Jul; 66(14):1246-8. PubMed ID: 19574593
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication guides scrutinized.
    Young D
    Am J Health Syst Pharm; 2007 Jul; 64(14):1464-6. PubMed ID: 17617493
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimizing look-alike generic mix-ups.
    Cohen MR; Davis NM
    Am Pharm; 1994 Mar; NS34(3):22-3. PubMed ID: 8192095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.